BD intensifies syringe output to meet U.S. demand amid China quality concerns

BD’s North Canaan plant has increased its output of syringes by more than 40% to meet the needs of U.S. healthcare customers after the FDA launched an ongoing investigation into quality issues with plastic syringes made in China.

Provided

BD intensifies syringe output to meet U.S. demand amid China quality concerns

NORTH CANAAN — Becton, Dickinson and Company (BD) has ramped up its production of syringes at its North Canaan plant in response to quality issues with plastic syringes imported from China which were uncovered late last year by the U.S. Food and Drug Administration (FDA).

BD, a leading global medical technology company and Northwest Connecticut’s largest employer, responded to the FDA’s recommendation that consumers, healthcare providers and healthcare facilities transition away from plastic syringes made in China by increasing its domestic manufacturing of syringes at the company’s Connecticut and Nebraska facilities.

Since January, BD’s 385,000-square-foot North Canaan plant has increased its output of syringes “by over 40% to meet the needs of U.S. healthcare customers,” according to Fallon McLoughlin, director of public relations and corporate communications for the Franklin Lakes, N.J.-based company.

“BD has achieved this increase by driving operational efficiencies and relocating some production lines from other BD plants,” said McLoughin.

“We’ve added over 100 full-time associates in the last year, and currently have more than 500 full-time associates and nearly 50 contingent associates,” she said of the North Canaan site, which began its operations in 1961 with eight employees at a 25,000-square-foot facility.

BD draws its employees from throughout Northwest Connecticut and neighboring New York.

McLaughlin noted that its Connecticut plant primarily manufactures small-size syringes, and syringe and needle combination products that are “critical to the delivery of healthcare.”

Operations take place around the clock, producing more than 2 billion medical devices each year that are sold in every region worldwide.

Responding to consumer needs

In March, Eric Borin, president of BD Medication Delivery Solutions, announced a statement saying: “BD has the capacity to support additional syringe demand and is further increasing U.S. production to help ensure continuity of patient care.”

Since the initial FDA safety communication in November 2023, he noted, “BD has increased domestic manufacturing of syringes in our Nebraska and Connecticut facilities to respond to customer needs. Ensuring the safety and quality of our products is the top priority at BD.”

Borin further noted at the time that “The latest FDA safety communication does not include any BD syringes. Over our more than 125-year history, we have served the health care system’s need for essential high quality medical products, including manufacturing 2 billion additional syringes and needles to support the global pandemic response to COVID-19.”

Syringe manufacturers in China cited

In late November 2023, the FDA announced its probe into reports of leaks, breakages and other quality problems with plastic syringes manufactured in China “that are used for injecting fluids into or withdrawing fluids from, the body,” according to the health regulator.

On March 14, the FDA issued an update on warning letters sent to three entities: Jiangsu Shenli Medical Production Co. Ltd, Medline Industries, LP and Sol-Millennium Medical Inc., describing violations related to the “sale and distribution of unauthorized plastic syringes that had not been cleared or approved by the FDA,” according to a new release.

“In addition, we are actively evaluating quality issues and performance testing failures with plastic syringes made by Jiangsu Caina Medical Co Ltd., a China-based manufacturer sited in the warning letter issued to Medline Industries, LP. The FDA will take additional steps as appropriate,” the FDA stated.

In its August 16 update, the FDA continued to recommend that healthcare providers “use syringes not manufactured in China, if possible.

“At this time, glass syringes, pre-filled syringes or syringes used for topical purposes are not included. If you only have syringes manufactured in China, then continue to use them as needed until you are able to use alternative syringes and closely monitor for leaks, breakage and other problems,” the FDA announced.

In March, BD was named to Fortune’s 2024 list of America’s Most Innovative Companies, and in September, the company announced that it had been named to TIME’s 2024 list of the World’s Best Companies based on employee feedback.

BD’s operations in North Canaan have also been recognized by the U.S. Environmental Protection Agency for achieving the Energy Star Challenge for Industry for energy reduction. The site is a landfill-free site where waste is reduced, recycled or converted into energy.

Latest News

Gilbert tops HVRHS 57-45

Gilbert's star guard Emily Arel scored 29 points through double coverage when Gilbert hosted HVRHS Jan. 21.

Riley Klein

WINSTED — Led by senior Emily Arel’s game-high 29 points, Gilbert advanced to a record of 8-3 this season with a 57-45 home court victory over Housatonic Valley Regional High School (7-5) Tuesday, Jan. 21.

Despite several players out due to illness, HVRHS played Gilbert close and trailed by just three points early in the fourth quarter. Arel led Gilbert on a late scoring run and closed out the win for the Yellowjackets.

Keep ReadingShow less
HVRHS boys win back-to-back games at home
Wes Allyn plays forward for HVRHS varsity basketball.
Photo by Riley Klein

FALLS VILLAGE — Housatonic Valley Regional High School boys varsity basketball hosted two home games last week and won them both.

On Tuesday, Jan. 21, the Mountaineers won 58-46 over Gilbert School. HVRHS was led offensively by Sam Marcus with 12 points, Anthony Labbadia with 10 points, and Wes Allyn with nine points. Gilbert (0-12) was led by Noah Holmes with 25 points and Josh Alexander with 14 points.

Keep ReadingShow less
'Gather' at Troutbeck

Romane Recalde speaking about her new business at Gather.

Natalia Zukerman

Hosted by Jason Klein and Sascha Lewis, an ongoing series called “Gather” at Troutbeck in Amenia brings together a curious crowd of local entrepreneurs, artists, and others with a story to tell for an intimate midday chat. On Thursday, Jan. 16, floral designer Romane Recalde, owner of the newly opened Le Jardin in Amenia, took center stage to share her journey from modeling in Miami to cultivating flowers in the Hudson Valley. Gather is a place to share stories, swap advice, and celebrate some of the unique businesses that make our area vibrant — all with a delicious lunch on the side. The gatherings are unconventional in the best way, with no agenda beyond good conversation and community building.

Recalde’s story isn’t just about creating a flower shop; it’s about a complete reinvention of self. “I hated Miami so much,” said the French-born Recalde, recalling her time in Florida before moving to New York. She worked as a model in New York, and eventually met her husband, James. Their pandemic escape to Turks and Caicos turned into a six-month stay, which in turn led them to Millbrook and finally to their home in Amenia, where Recalde’s connection to nature blossomed.

Keep ReadingShow less
Mad Rose opens ‘Assembled’ exhibition
Mad Rose Gallery director Michael Flowers contributed to the gallery's "Assembled" exhibit with a series of collaged landscape photographs
Nathan Miller

Mad Rose Gallery’s “Assembled” exhibition opened Saturday, Jan. 18, with a public reception.

The eclectic exhibition — on view until March 2 at the gallery on the intersection of Routes 22 and 44 in Millerton — gathers together work from a group of diverse artists with decades of experience between them. The exhibition itself is true to the name, featuring photographs, sculptures, drawings and mixed media works in all shapes and sizes.

Keep ReadingShow less